MONTREAL, Oct. 8, 2019 /PRNewswire-PRWeb/ -- Cryopak Canada and Launchworks Manufacturing Lab are announcing a collaboration
LIFT will support the diagnostic device industry's objectives by combining the NRC's expertise in sciences, materials, and design with Launchworks' expertise in cGMP and ISO 13485 manufacturing at clinical and industrial scale. Through this partnership, the organizations will work with diagnostic companies to translate microfluidic application ideas into workable devices.
"Microfluidic diagnostic companies are driving device development to be faster, easier to use and more cost effective," said Jeff Kelly, VP of Corporate Development for Cryopak. "The NRC's 20 years of experience in scientific development combined with Launchworks ISO 13485 manufacturing capabilities will provide point-of-care diagnostic companies a complete and cost-effective service solution to rapidly bring their ideas to successful commercialization."
Design and development will be done at the NRC in Montréal, with manufacturing to be done initially at the LaunchWorks facility in Beverly, MA, and plans to develop an additional manufacturing facility with Cryopak Canada in the near future. Cryopak and LaunchWorks are affiliate companies both owned by TCP Reliable.
For further information, please visit http://www.LaunchWorksML.com, http://www.cryopak.ca, or https://nrc.canada.ca/en
SOURCE LaunchWorks Manufacturing Lab